Translational Development Acquisition Corp. (TDAC) |
| 10.87 -0.03 (-0.27%) 09-16 16:00 |
| Open: | 10.93 |
| High: | 10.93 |
| Low: | 10.86 |
| Volume: | 9,227 |
| Market Cap: | 268(M) |
| PE Ratio: | 42.86 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Shell Companies |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 10.95 |
| Resistance 1: | 10.90 |
| Pivot price: | 10.86 |
| Support 1: | 10.82 |
| Support 2: | 9.00 |
| 52w High: | 10.95 |
| 52w Low: | 10.34 |
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
| EPS | 0.260 |
| Book Value | -0.300 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -0.5 |
| Return on Equity (ttm) | 0.0 |
Wed, 19 Aug 2026
Translational Development Investor Alert: Kahn Swick & Foti, LLC Investigates Translational Development Acquisition Corp. - TDAC - Business Wire
Fri, 14 Aug 2026
Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC - stocktitan.net
Sat, 01 Aug 2026
ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment - Pulse 2.0
Tue, 28 Jul 2026
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment - moomoo.com
Tue, 28 Jul 2026
ProLogium and Translational Development Acquisition Corp. - GlobeNewswire
Mon, 22 Jun 2026
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |